Li Xin, Lu Zhong
Department of Oncology, Affiliated Hospital of Weifang Medical College, Weifang, Shandong 261053, P.R. China.
Graduate School, Weifang Medical College, Weifang, Shandong 261053, P.R. China.
Oncol Lett. 2022 Jun;23(6):198. doi: 10.3892/ol.2022.13319. Epub 2022 May 5.
Lung adenocarcinoma (LUAD) has a high morbidity and mortality rate worldwide, and its growth and metastasis require angiogenesis. The density of microvessels in LUAD is positively correlated with metastasis and recurrence. Von Willebrand factor (VWF) is a multifunctional glycoprotein in blood plasma. Recent evidence shows that VWF inhibits angiogenesis through regulation of angiopoietin-2 (Ang-2) and integrin αvβ3. LUAD patients exhibit an increase in the plasma VWF/ADAMTS-13 ratio. Gene expression profiles of LUAD tissues indicate that is differentially expressed in LUAD tissues compared to normal tissues. GATA binding protein 3 (GATA3) transcription factor may mediate expression in LUAD. In this review, we summarize the role of VWF in LUAD and its regulatory mechanisms. We also discuss the potential of VWF as a diagnostic indicator and therapeutic target of LUAD.
肺腺癌(LUAD)在全球范围内具有较高的发病率和死亡率,其生长和转移需要血管生成。LUAD中的微血管密度与转移和复发呈正相关。血管性血友病因子(VWF)是血浆中的一种多功能糖蛋白。最近的证据表明,VWF通过调节血管生成素-2(Ang-2)和整合素αvβ3来抑制血管生成。LUAD患者血浆VWF/ADAMTS-13比值升高。LUAD组织的基因表达谱表明,与正常组织相比, 在LUAD组织中差异表达。GATA结合蛋白3(GATA3)转录因子可能介导LUAD中的 表达。在本综述中,我们总结了VWF在LUAD中的作用及其调控机制。我们还讨论了VWF作为LUAD诊断指标和治疗靶点的潜力。